Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 in the page footer. This indicates a minor version update with no evident changes to the study details presented on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision tag was updated to v3.6.5 from v3.6.4, indicating a minor update to the page. There are no visible changes to the study details or content.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded a Publications section with a PubMed citation for a 2025 paper and a note that PubMed data auto-populates. Updated the revision entry to v3.6.4, replacing v3.6.3.SummaryDifference0.3%

- Check63 days agoChange DetectedThe revision number on the page was updated from v3.6.2 to v3.6.3, representing a software update to the page's rendering or maintenance without altering the study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a page update. This reflects versioning just for the page and does not alter the study data or documented requirements.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page adds new navigation/help items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting, while replacing the Revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.